You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KPTI Sale Disclosure
Poulton Stuart · SEC Form 4 · Filed Jul 30, 2026
Sale
Calculated transaction value
$1.34K
Poulton Stuart EVP, Chief Development Officer
KPTI
Transaction date
Jul 28, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed 2 days later
KPTI daily price context
Close on/before transaction
$7.09
Jul 28, 2026
First close after public filing
$1.92
Jul 31, 2026
30-day return after filing
+7.29%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 189 shares @ $7.1
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-326290
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.34K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Karyopharm Therapeutics Inc. KPTI Current | Sale | Jul 28, 2026 | $1.34K |